OGE
NYSE · Utilities
Oge Energy Corp
$47.02
+0.23 (+0.49%)
OGE News30 articles
GAO Audit Casts Doubt on DOGE Savings Claims, Contractors Rally
A GAO audit reveals over half of DOGE's reported contract savings lack proper documentation, yet federal services stocks rise as contractors report strong funded backlogs.
Kroger Egg Recall: Minimal Impact on US Supply, Shares Dip
Midwest Poultry recalls 1.6M dozen eggs sold at Kroger and other retailers, representing 0.25% of US monthly output. No illnesses reported.
Kroger's Pricing Strategy Outshines Walmart in Latest Basket Comparison
Kroger (NYSE:KR) edged out Walmart (NASDAQ:WMT) by 95 cents in a 15-item store-brand basket comparison, showcasing its pricing strategy and margin investments.
Plug Power Shares Slide 5.5% on Target Cut Despite Major Hydrogen Deal
Plug Power shares fell 5.5% Friday after Susquehanna cut its target by $1.25, wiping $1.75 billion in implied equity value, as a 50-MW hydrogen order from Orica failed to calm investor worries about cash flow.
Plug Power Shares Slip Despite 50 MW Electrolyzer Order for Australian Hydrogen Hub
Plug Power shares dropped for a third session despite a major 50 MW electrolyzer order for Australia's largest renewable hydrogen project, as investors focus on cash burn and near-term profitability.
Plug Power Shares Dip on Australian Order Highlighting Hydrogen Subsidy Dependence
Plug Power shares slipped 0.9% after landing a 50 MW electrolyzer order in Australia, where AU$432 million in subsidies highlight the hydrogen market's dependence on government backing.
Kroger's $1.65B Giant Eagle Buy: Low Multiple, High Ambition
Kroger buys Giant Eagle for $1.65 billion, a low 0.18x sales multiple, adding $9 billion in revenue. Deal faces antitrust review but aims to boost margins and EPS by 2027.
AbbVie Surges $17.8 Billion in Market Cap, Surpassing Apogee Deal Value
AbbVie shares soared 3.99% to $261.07, adding $17.8B in market value—more than the $10.9B Apogee deal. The stock now trades above analyst targets, setting up a key Q2 earnings report.
Kroger Acquires Giant Eagle for $1.65B in Targeted Regional Expansion
Kroger has agreed to acquire Giant Eagle for $1.65 billion, a deal valued at just 0.18 times the regional grocer's annual sales, signaling a focused regional strategy.
AbbVie's $65B Surge Outpaces Apogee Acquisition Cost by Sixfold
AbbVie's stock surge added $65B in market cap, six times its $10.9B Apogee deal cost, as Skyrizi approval and immunology demand offset Humira declines.
Kroger's Private Label Scrutiny Rises After USDA Chicken Alert
A USDA alert flagged mislabeled Private Selection chicken at Kroger in nine states, but no adverse reactions were reported. The stock closed Friday at $57.73.
Shuttle Pharma Soars on Dogecoin Mining Entry; Volume Spikes 70x
Shuttle Pharmaceuticals jumped 27% on news its United Dogecoin unit bought miners and secured a hydroelectric site, with volume surging 70x.
Plug Power's Denmark Project Highlights Green Hydrogen Scaling Challenges
Plug Power shares rose 0.4% to $2.62 after completing a 5 MW electrolyzer project in Denmark, which produces less than 4% of its U.S. capacity. The small scale underscores the challenges in hydrogen scaling.
AbbVie Acquires Apogee Therapeutics for $10.9B in Cash, Bolstering Pipeline
AbbVie announced a $10.9 billion cash acquisition of Apogee Therapeutics, adding a promising eczema treatment to its pipeline as it seeks to offset declining Humira sales.
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion in Cash
Apogee Therapeutics stock jumped 47% after AbbVie agreed to buy the company for $135.11 per share in cash, adding late-stage eczema drug zumilokibart.
AbbVie to Buy Apogee in $10.9B Deal to Boost Immunology Pipeline
AbbVie acquires Apogee Therapeutics for $10.9 billion, paying a 49.49% premium for experimental eczema drug zumilokibart, as it seeks to bolster its immunology franchise.
AbbVie Nears $10.9B Apogee Takeover, Healthcare Stocks in Focus
AbbVie is reportedly close to acquiring Apogee Therapeutics for $10.9 billion in cash, offering a roughly 60% premium. A deal could be announced Monday, putting healthcare stocks in the spotlight.
Plug Power Stock Jumps 7.5% as Tax Credit Sale Boosts Liquidity, Hydrogen Sector Rallies
Plug Power shares jumped 7.55% on Thursday, driven by a $39.2 million tax credit sale and improved gross margins, as the hydrogen sector broadly rallied.
Kroger Shares Dip as Q1 Profit Misses Estimates Despite Revenue Beat
Kroger shares dropped 3% premarket after Q1 adjusted profit missed estimates by a cent, despite a sales beat. Margin pressure from price cuts and transport costs raised investor doubts.
PEPE Outpaces DOGE and SHIB as Meme Coins Test Key Resistance Levels
PEPE outperformed DOGE and SHIB on short-term momentum, but analysts caution the rally could end quickly if key resistance levels aren't breached.
Rogers Corp. Surges on AI Materials Demand; Global Markets React to Regulatory and IPO News
Rogers Corp. shares surged 4% on demand growth and AI materials progress. China's regulator warns against AI stock speculation. BSE shares fall as NSE prepares for a major IPO. C3.ai may be overvalued by 45%.
Plug Power Slips Again as Hydrogen Rally Faces Profitability Test
Plug Power shares fell 4.1% to $3.95 on Friday, as the hydrogen rally faces a critical test of profitability and cash management.
Plug Power Stock Holds Above $4 as Hydrogen Optimism Returns
Plug Power shares trade near $4.12 after a volatile week, with Q1 revenue growing 22% and a $246M net loss. The company advances its UK green hydrogen project and targets EBITDAS profitability by Q4.
Plug Power Stock Steadies as UK Hydrogen Project Advances
Plug Power shares closed Tuesday up 1.59% at $3.84. The company's Barrow Green Hydrogen project in the UK has reached final investment decision, but profitability remains elusive with a Q1 net loss of $246 million.
Plug Power Ends Flat After Volatile Week; Barrow Hydrogen Project Reaches FID
Plug Power shares ended the week unchanged at $3.78 following a volatile trading period. The Barrow Green Hydrogen project reached final investment decision, but cash burn and margins remain key investor concerns.
Apellis Delisted After Biogen's $5.3B Acquisition Closes
Biogen closed its $5.3 billion acquisition of Apellis, ending APLS trading on Nasdaq. Shareholders got $41 per share plus a CVR linked to Syfovre sales milestones.
Plug Power's UK Green Hydrogen Project Reaches FID, Stock Flat
Plug Power's Barrow Green Hydrogen project hits FID, supplying six 5 MW electrolyzers to cut Kimberly-Clark's gas use 50%. Stock flat at $3.31 as cash risks remain.
Plug Power Advances UK Hydrogen Project Amid Cash Concerns
Plug Power shares climbed 1.2% to $3.35 after achieving final investment decision for its 30-MW green hydrogen project in the UK, though cash constraints and negative margins remain key concerns.
Biogen Closes Apellis Takeover; Focus Shifts to Syfovre Milestones
Biogen has completed its $5.6 billion acquisition of Apellis Pharmaceuticals, delisting APLS from Nasdaq. Shareholders received $41 per share plus a contingent value right linked to Syfovre sales targets.
Kroger Stock Climbs as CEO Focuses on Price Strategy
Kroger shares gained 3.8% in midday trading Tuesday, outpacing Walmart and Costco, as investors focus on new CEO Greg Foran's pricing strategy.